| Literature DB >> 30224984 |
Ning Chen1, Weixia Li1, Shuchao Wu2, Yan Zhu1.
Abstract
A novel method combining high-performance liquid chromatography with online post-column electrochemical derivatization and fluorescence detection was established for the detection of reserpine in mouse serum. Reserpine separation was conducted using a C18 column with 5 mM H3PO4 and acetonitrile (55/45, v/v) as eluent. Reserpine was then electro-oxidized into a strongly fluorescent compound using an electrolytic cell device. Detection parameters, such as potential and fluorescence wavelength, were optimized. The linearity of the proposed method ranged from 0.01 to 5.0 mg l-1 with a correlation coefficient of 0.9997. The limit of qualification (S/N = 10) and limit of detection (S/N = 3) were 9.7 and 2.9 µg l-1, respectively. Resperine recoveries from spiked blank and drug-treated mouse serum samples ranged from 92.0 to 115%.Entities:
Keywords: electrochemical derivatization; online; reserpine; serum
Year: 2018 PMID: 30224984 PMCID: PMC6124075 DOI: 10.1098/rsos.171948
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 2.963
Figure 1.Schematic of HPLC/EC/FLD system.
Figure 2.Structure of the electrolytic cell device. CEM, cation-exchange membrane.
Figure 3.Electro-oxidation mechanism of reserpine.
Figure 4.(a) Excitation spectra and emission spectra of reserpine. Experimental condition: E = 0 V; (b) excitation spectra and emission spectra of electro-oxidized product. Experimental condition: E = 0.9 V.
Figure 5.Optimization: (a) dependence of the peak area and peak height on pH; (b) effect of potential on the fluorescence signal of reserpine (5 mg l−1); (c) dependence of the peak area and peak height on ACN ratio; (d) dependence of the peak area and peak height on temperature; (e) chromatograms of electro-oxidized reserpine with different temperature.
Recoveries of spiked reserpine and assay precision for reserpine detection in mouse serum.
| sample | found (mg l−1) | precision (%R.S.D., | spiked (mg l−1) | detected (mg l−1) | recovery (%) | precision (%R.S.D., |
|---|---|---|---|---|---|---|
| sample 1 | 1.02 | 3.0% | 0.100 | 1.16 | 105 | 1.4 |
| intra-day | ||||||
| sample 2 | 0.050 | 0.048 | 96.2 | 6.4 | ||
| / | / | 0.100 | 0.111 | 111 | 3.9 | |
| 0.500 | 0.575 | 115 | 1.4 | |||
| inter-day | ||||||
| 0.050 | 0.046 | 92.0 | 3.5 | |||
| 0.100 | 0.095 | 95.1 | 5.3 | |||
| 0.500 | 0.571 | 114 | 5.5 |
Sample 1: drug-treated mouse serum group.
Sample 2: blank control serum group.
Comparison of the proposed method with other reported methods. SECNT/CPE-modified PANI, single-walled carbon nanotube paste electrode modified with polyaniline; MWNT, modified GCE, multi-walled carbon nanotube-modified glassy carbon electrode; FI, flow injection; LC, liquid chromatography.
| methods | sample | treatment | detector | linearity range (mg l−1) | LOD (μg l−1) | ref. |
|---|---|---|---|---|---|---|
| HPLC | mouse serum | post-column electrochemical derivatization | FLD | 0.01–5.0 | 2.9 | present work |
| HPLC | herbs | drying, dissolution and extraction | UV | 1.56–200 | 390 | [ |
| capillary electrophoresis | extraction, centrifugation and concentration | DAD | 10–100 | 500 | [ | |
| capillary electrophoresis | urine | filtration | ECL | 0.608–60.8 | 42.60 | [ |
| chemiluminescence | tablet | oxidation with potassium permanganate | chemiluminometer | 0.100–3.00 | 48 | [ |
| adsorptive stripping voltammetry with SWCNT/CPE-modified PANI | plant sample | drying, acid dissolution and concentration | ECD | 0.085–0.87 | 0.407 | [ |
| adsorptive stripping voltammetry with MWNT-modified GCE | tablet and injection | 100-fold dilution | ECD | 0.012–6.08 | 4.5 | [ |
| FI photochemical spectrofluorimetry | tablet | acetone sensitization | spetrofluorimeter | 0.01–0.75 | 0.45 | [ |
| LC | equine plasma | liquid–liquid extraction solid-phase extraction | MS/MS | 0.010–5.0 μg l−1; 0. 100–5.0 μg l−1 | 0.01 | [ |
| HPLC | human plasma | liquid–liquid extraction | MS/MS | 0.04–30.00 μg l−1 | / | [ |
Figure 6.Chromatograms of reserpine in mouse serum as obtained through the HPLC/EC/FLD system. (A) Blank mouse serum sample spiked with 2 mg l−1 reserpine, (B) drug-treated mouse serum sample and (C) blank control mouse serum sample. Column: Acclaim 120 C18 column. Eluent: 5 mM H3PO4 and ACN (55/45, v/v).